Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ongentys
Ongentys
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Sat, 05/16/20 - 11:49 am
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
FDA Approves Neurocrine Biosciences' Parkinson's Drug
Motley Fool
Mon, 04/27/20 - 07:35 pm
Neurocrine
FDA
Ongentys
Parkinson's Disease
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Endpoints
Thu, 02/9/17 - 09:24 pm
Neurocrine
Parkinson's Disease
Ongentys
Bial